MaxCyte (MXCT) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

$3.88

-0.06 (-1.52%)

(As of 04/18/2024 ET)

Source

Source	Headline
	MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024 globenewswire.com - April 10 at 8:05 AM
	Mesa Laboratories maintains quarterly dividend of $0.16 msn.com - April 5 at 1:52 AM
	MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs) globenewswire.com - April 2 at 8:05 AM
	Insider Selling: MaxCyte, Inc. (NASDAQ:MXCT) Director Sells 5,000 Shares of Stock insidertrades.com - March 29 at 8:56 AM
	John Joseph Johnston Sells 5,000 Shares of MaxCyte, Inc. (NASDAQ:MXCT) Stock marketbeat.com - March 28 at 7:55 PM
	Willis Investment Counsel Invests $2.59 Million in MaxCyte, Inc. (NASDAQ:MXCT) marketbeat.com - March 20 at 6:53 PM
	Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term finance.yahoo.com - March 17 at 8:04 AM
	MaxCyte, Inc: MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance finanznachrichten.de - March 15 at 8:07 AM
	MaxCyte, Inc. (LON:MXCT) Just Reported And Analysts Have Been Cutting Their Estimates finance.yahoo.com - March 14 at 10:45 AM
	MaxCyte (NASDAQ:MXCT) Receives Outperform Rating from William Blair marketbeat.com - March 13 at 10:27 AM
	MaxCyte Shares Rise 13% After 4Q Beat, Reaffirmed Guidance marketwatch.com - March 13 at 8:22 AM
	MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance globenewswire.com - March 12 at 4:05 PM
	MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance globenewswire.com - March 12 at 4:05 PM
	MaxCyte, Inc.: MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results finanznachrichten.de - March 6 at 4:53 PM
	William Blair Reiterates "Outperform" Rating for MaxCyte (NASDAQ:MXCT) marketbeat.com - March 5 at 11:43 AM
	MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results globenewswire.com - March 4 at 4:05 PM
	MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results globenewswire.com - March 4 at 4:05 PM
	Blair William & Co. IL Boosts Stock Position in MaxCyte, Inc. (NASDAQ:MXCT) marketbeat.com - February 19 at 5:57 AM
	Maven Securities LTD Buys New Position in MaxCyte, Inc. (NASDAQ:MXCT) marketbeat.com - February 16 at 8:21 AM
	MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences finance.yahoo.com - February 9 at 8:25 AM
	MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers finance.yahoo.com - January 30 at 9:41 AM
	MaxCyte Signs SPL Agreement With Imugene markets.businessinsider.com - January 23 at 1:02 PM
	Why Cell Engineering Company MaxCyte Shares Are Up Today msn.com - January 9 at 1:07 PM
	COMM, NKTX and AVIR are among after hour movers seekingalpha.com - January 9 at 8:07 AM
	MaxCyte Stock (NASDAQ:MXCT) Dividends: History, Yield and Dates benzinga.com - January 5 at 9:06 AM
	MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline finance.yahoo.com - January 3 at 9:13 AM
	MaxCyte, Inc. (NASDAQ:MXCT) Sees Significant Growth in Short Interest marketbeat.com - January 2 at 8:54 PM
	MaxCyte, Inc: MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director finanznachrichten.de - January 2 at 7:55 AM
	MaxCyte gets new CEO and President msn.com - January 2 at 7:55 AM
	MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director finance.yahoo.com - January 2 at 2:55 AM
	MaxCyte, Inc. (NASDAQ:MXCT) Director John Joseph Johnston Sells 5,000 Shares marketbeat.com - December 28 at 6:44 PM
	With 74% institutional ownership, MaxCyte, Inc. (LON:MXCT) is a favorite amongst the big guns finance.yahoo.com - December 15 at 7:35 AM
	FY2023 EPS Estimates for MaxCyte, Inc. (NASDAQ:MXCT) Raised by Analyst marketbeat.com - December 14 at 7:13 AM
	MaxCyte Names Maher Masoud CEO marketwatch.com - December 11 at 5:49 PM
	MaxCyte announces departure of founder and CEO Doug Doerfler msn.com - December 11 at 5:49 PM
	MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023 markets.businessinsider.com - December 11 at 5:49 PM
	MaxCyte, Inc. (NASDAQ:MXCT) Stock Holdings Trimmed by Blue Water Life Science Advisors LP marketbeat.com - December 11 at 7:55 AM
	Insider Sell Alert: President and CEO Douglas Doerfler Sells 124,450 Shares of MaxCyte Inc (MXCT) finance.yahoo.com - December 7 at 1:34 PM
	MaxCyte, Inc.: MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance finanznachrichten.de - November 9 at 9:31 AM
	MaxCyte Inc MXCT morningstar.com - November 8 at 7:27 PM
	MaxCyte shares plunge after Rockville biotech firm sharply lowers 2023 revenue outook bizjournals.com - October 5 at 2:42 PM
	Cell Engineering MaxCyte Faces Challenge, Analysts Express Concerns Over Near-Term Prospects Amid Revenue Decline markets.businessinsider.com - October 5 at 2:42 PM
	MaxCyte, Inc: MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance finanznachrichten.de - October 5 at 9:41 AM
	MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session benzinga.com - October 5 at 9:41 AM
	The past year for MaxCyte (LON:MXCT) investors has not been profitable finance.yahoo.com - October 5 at 9:41 AM
	Why Is MaxCyte (MXCT) Stock Down 21% Today? investorplace.com - October 5 at 9:16 AM
	MaxCyte Shares Sink 21% Amid Lower-Than-Expected FY Revenue Views marketwatch.com - October 4 at 6:52 PM
	MaxCyte, Inc. (NASDAQ:MXCT) Shares Bought by Granahan Investment Management LLC marketbeat.com - September 11 at 5:49 AM
	MaxCyte, Inc: MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing finanznachrichten.de - September 6 at 6:06 PM
	MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing finance.yahoo.com - September 6 at 8:34 AM

Get MaxCyte News Delivered to You Automatically

Your Money is Not Safe (Ad)

Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

CLICK HERE TO GET YOUR GUIDE NOW

MXCT Media Mentions By Week

MXCT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MXCT
News Sentiment
▼
0.00

0.51
▲
Average
Medical
News Sentiment

MXCT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MXCT Articles
This Week
▼
0

1
▲
MXCT Articles
Average Week

Get MaxCyte News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:MXCT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MaxCyte (MXCT) News Today

MXCT Media Mentions By Week

MXCT Media Sentiment

MXCT News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info